Global socioeconomic inequality in the burden of communicable and non-communicable diseases and injuries: an analysis on global burden of disease study 2019.
Burden of diseases
Communicable diseases
Human development index
Inequality
Injuries
Non-communicable
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
28 09 2021
28 09 2021
Historique:
received:
15
01
2021
accepted:
15
09
2021
entrez:
29
9
2021
pubmed:
30
9
2021
medline:
3
11
2021
Statut:
epublish
Résumé
Examining the distribution of the burden of different communicable and non-communicable diseases and injuries worldwide can present proper evidence to global policymakers to deal with health inequality. The present study aimed to determine socioeconomic inequality in the burden of 25 groups of diseases between countries around the world in 2019. In the current study data according to 204 countries in the world was gathered from the Human Development Report and the Global Burden of Diseases study. Variables referring to incidence, prevalence, years of life lost (YLL), years lived with disability (YLD) and disability adjusted life years (DALY) resulting by 25 groups of diseases and injuries also human development index was applied for the analysis. For measurement of socioeconomic inequality, concentration index (CI) and curve was applied. CI is considered as one of the popular measures for inequality measurement. It ranges from - 1 to + 1. A positive value implies that a variable is concentrated among the higher socioeconomic status population and vice versa. The findings showed that CI of the incidence, prevalence, YLL, YLD and DALY for all causes were - 0.0255, - 0.0035, - 0.1773, 0.0718 and - 0.0973, respectively. CI for total Communicable, Maternal, Neonatal, and Nutritional Diseases (CMNNDs) incidence, prevalence, YLL, YLD and DALY were estimated as - 0.0495, - 0.1355, - 0.5585, - 0.2801 and - 0.5203, respectively. Moreover, estimates indicated that CIs of incidence, prevalence, YLL, YLD and DALY for Non-Communicable Diseases (NCDs) were 0.1488, 0.1218, 0.1552, 0.1847 and 0.1669, respectively. Regarding injuries, the CIs of incidence, prevalence, YLL, YLD and DALY were determined as 0.0212, 0.1364, - 0.1605, 0.1146 and 0.3316, respectively. In the CMNNDs group, highest and lowest CI of DALY were related to the respiratory infections and tuberculosis (- 0.4291) and neglected tropical diseases and malaria (- 0.6872). Regarding NCDs, the highest and lowest CI for DALY is determined for neoplasms (0.3192) and other NCDs (- 0.0784). Moreover, the maximum and minimum of CI of DALY for injuries group were related to the transport injuries (0.0421) and unintentional injuries (- 0.0297). The distribution of all-causes and CMNNDs burden were more concentrated in low-HDI countries and there are pro-poor inequality. However, there is a pro-rich inequality for NCDs' burden i.e. it was concentrated in high-HDI countries. On the other hand, the concentration of DALY, YLD, prevalence, and incidence in injuries was observed in the countries with higher HDI, while YLL was concentrated in low-HDI countries.
Sections du résumé
BACKGROUND
Examining the distribution of the burden of different communicable and non-communicable diseases and injuries worldwide can present proper evidence to global policymakers to deal with health inequality. The present study aimed to determine socioeconomic inequality in the burden of 25 groups of diseases between countries around the world in 2019.
METHODS
In the current study data according to 204 countries in the world was gathered from the Human Development Report and the Global Burden of Diseases study. Variables referring to incidence, prevalence, years of life lost (YLL), years lived with disability (YLD) and disability adjusted life years (DALY) resulting by 25 groups of diseases and injuries also human development index was applied for the analysis. For measurement of socioeconomic inequality, concentration index (CI) and curve was applied. CI is considered as one of the popular measures for inequality measurement. It ranges from - 1 to + 1. A positive value implies that a variable is concentrated among the higher socioeconomic status population and vice versa.
RESULTS
The findings showed that CI of the incidence, prevalence, YLL, YLD and DALY for all causes were - 0.0255, - 0.0035, - 0.1773, 0.0718 and - 0.0973, respectively. CI for total Communicable, Maternal, Neonatal, and Nutritional Diseases (CMNNDs) incidence, prevalence, YLL, YLD and DALY were estimated as - 0.0495, - 0.1355, - 0.5585, - 0.2801 and - 0.5203, respectively. Moreover, estimates indicated that CIs of incidence, prevalence, YLL, YLD and DALY for Non-Communicable Diseases (NCDs) were 0.1488, 0.1218, 0.1552, 0.1847 and 0.1669, respectively. Regarding injuries, the CIs of incidence, prevalence, YLL, YLD and DALY were determined as 0.0212, 0.1364, - 0.1605, 0.1146 and 0.3316, respectively. In the CMNNDs group, highest and lowest CI of DALY were related to the respiratory infections and tuberculosis (- 0.4291) and neglected tropical diseases and malaria (- 0.6872). Regarding NCDs, the highest and lowest CI for DALY is determined for neoplasms (0.3192) and other NCDs (- 0.0784). Moreover, the maximum and minimum of CI of DALY for injuries group were related to the transport injuries (0.0421) and unintentional injuries (- 0.0297).
CONCLUSIONS
The distribution of all-causes and CMNNDs burden were more concentrated in low-HDI countries and there are pro-poor inequality. However, there is a pro-rich inequality for NCDs' burden i.e. it was concentrated in high-HDI countries. On the other hand, the concentration of DALY, YLD, prevalence, and incidence in injuries was observed in the countries with higher HDI, while YLL was concentrated in low-HDI countries.
Identifiants
pubmed: 34583668
doi: 10.1186/s12889-021-11793-7
pii: 10.1186/s12889-021-11793-7
pmc: PMC8480106
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1771Informations de copyright
© 2021. The Author(s).
Références
Can Nurse. 2005 May;101(5):22-4
pubmed: 16035514
Diabetes Care. 2006 Jun;29(6):1433-8
pubmed: 16732040
Int J Epidemiol. 2012 Oct;41(5):1315-27
pubmed: 22366083
Accid Anal Prev. 2012 Mar;45:99-106
pubmed: 22269490
Epidemiol Infect. 2021 Apr 19;149:e159
pubmed: 33866988
Infect Dis Poverty. 2020 Jan 28;9(1):10
pubmed: 31987053
Lancet. 2013 Feb 16;381(9866):585-97
pubmed: 23410608
BMC Public Health. 2010 Jun 16;10:344
pubmed: 20553582
J Assoc Physicians India. 2003 May;51:470-7
pubmed: 12974428
PLoS One. 2019 Jun 11;14(6):e0218215
pubmed: 31185042
Diabetes Care. 2004 Sep;27(9):2234-40
pubmed: 15333490
Int J Epidemiol. 2007 Feb;36(1):50-7
pubmed: 17085457
PLoS One. 2013 Jul 15;8(7):e68219
pubmed: 23869213
BMC Public Health. 2015 Sep 18;15:914
pubmed: 26385563
J Epidemiol Community Health. 2003 Apr;57(4):254-8
pubmed: 12646539
J Diabetes Metab Disord. 2015 Feb 25;14:8
pubmed: 25806357
Nutrients. 2014 Apr 02;6(4):1374-93
pubmed: 24699195
Am J Clin Nutr. 2008 May;87(5):1107-17
pubmed: 18469226
BMC Neurol. 2013 Sep 26;13:128
pubmed: 24070256
PLoS Negl Trop Dis. 2016 May 12;10(5):e0004560
pubmed: 27171193
Annu Rev Public Health. 2006;27:167-94
pubmed: 16533114
Prev Med. 2010 Nov;51(5):408-11
pubmed: 20817021
Br Med Bull. 2014 Sep;111(1):31-44
pubmed: 25190759
BMJ Open. 2012 Jul 18;2(4):
pubmed: 22815470
PLoS Negl Trop Dis. 2009 Oct 27;3(10):e539
pubmed: 19859530
Soc Sci Med. 1991;33(5):545-57
pubmed: 1962226
Diabetes Care. 2007 Jun;30(6):1562-6
pubmed: 17372155
Heart. 2006 Apr;92(4):461-7
pubmed: 16216862
BMC Public Health. 2013 Nov 04;13:1037
pubmed: 24180366
PLoS One. 2016 Nov 30;11(11):e0167140
pubmed: 27902760
Acta Neurol Scand. 2019 Nov;140(5):328-335
pubmed: 31291697
BMJ. 2007 Sep 29;335(7621):628-9
pubmed: 17901476
J Health Soc Behav. 2010;51 Suppl:S28-40
pubmed: 20943581
Int J Cardiol. 2010 Aug 6;143(1):100-2
pubmed: 19097658
Diabet Med. 2003 Nov;20(11):921-9
pubmed: 14632718
Cardiovasc J Afr. 2013 May;24(4):141-5
pubmed: 24217047